CCL2 and central nervous system cancer: Glioma cells constitutively secrete C–C motif chemokine ligand 2 (CCL2), which converts Th2 lymphocytes into immunosuppressive T regulatory (Treg) cells and macrophages into the pro-neoplastic M2 phenotype [11].